Cordant Inc’s Amedisys AMED Stock Holding History

Cordant Inc’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11	Closed	-$2K	–	118
2022 Q1	$2K	Buy	+11	New	+$1.64K	﹤0.01%	574
2021 Q4	–	Sell	-5	Closed	-$1K	–	91
2021 Q3	$1K	Buy	+5	New	+$1.04K	﹤0.01%	209

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Cordant Inc's AMED Position: Q2 2022 in Review

Cordant Inc sold out of Amedisys (AMED) in Q2 2022, closing a stake of 11 shares — an estimated $2K sold.

Cordant Inc first reported a position in AMED in Q3 2021 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

Cordant Inc reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 11 Amedisys shares in Q2 2022, an estimated $2K.
Cordant Inc first reported a position in Amedisys in Q3 2021 and held it in 2 quarters.
Cordant Inc's Amedisys position peaked at $2K in Q1 2022.
288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.